Basic Medical Theory Research

[1] Zhou M, Wang H, Zeng X,etc. Mortality, morbidity, and risk factors in China and its provinces,1990-2017:a systema tic analysis for the Global Burden of Disease Study 2017[J]. Lancet(London, England),Elsevier,2019,394(10204):1145.
[2] Sung H,Ferlay J,Siegel R L,etc. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA: A Cancer Journal for Clinicians,2021,71(3):209-249.
[3] Rodríguez-Perálvarez M, Luong T V, Andreana L, etc. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability[J]. Annals of Surgical Oncology,2013,20(1):325-339.
[4] Ghajar C M. Metastasis prevention by targeting the dormant niche[J].Nature reviews.Cancer,2015,15(4): 238–247.
[5] Famularo S, Piardi T, Molfino S,etc. Factors Affecting Local and Intra Hepatic Distant Recurrence After Surgery for Hcc: An Alternative Perspective on Microvascular Invasion and Satellitosis-A Western European Multicentre Study[J].Journ al of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract,2021,25(1):104-111.
[6] Xiong Y,Cao P,Lei X,etc.Accurate prediction of microva scular invasion occurrence and effective prognostic estimat ion for patients with hepatocellular carcinoma after radical surgical treatment[J].World Journal of Surgical Oncology,2022,20(1):328.
[7] Chong H-H,Yang L,Sheng R-F,etc.Multi-scale and multi -parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma≤5 cm[J].European Radiology, 2021,31(7):4824-4838.
[8] Shen A, Liu M, Zheng D, etc. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocell ular carcinoma with microvascular invasion: A systematic rev iew and meta-analysis[J]. Clinics and Research in Hepatology and Gastroenterology,2020,44(2):142-154.
[9] Jiang Y-Q,Cao S-E,Cao S,etc.Preoperative identificat ion of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning[J]. Journal of Cancer Research and Clinical Oncology,2021,147(3):821-833.
[10] Ye J, Wu D, Wu P, etc. The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment[J]. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine,2014,35(5):3945-3951.
[11] Whittaker S, Marais R, Zhu A X. The role of signaling pathways in the development and treatment of hepatocellularcarcinoma[J].Oncogene,2010,29(36):4989-5005.
[12] Zeng F,Chen B,Zeng J,etc.Preoperative neutrophillymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma:A meta-analysis[J].The Internat ional Journal of Biological Markers,2019,34(3):213-220.
[13] Qin L,Li C, Xie F, etc. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinic ally significant portal hypertension after liver resection?[J].BioScience Trends,2020,14(4):297-303.
[14] Wang D, Hu X, Xiao L, etc. Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Progno sis of Patients with HCC[J].Journal of Gastrointestinal Surgery, 2021,25(2):421-427.
[15] Wu Y,Tu C,Shao C.Inflammatory indexes in preoperat ive blood routine to predict early recurrence of hepatocell ular carcinoma after curative hepatectomy[J]. BMC Surgery, 2021,21(1):178.
[16] 翟张凯,田云龙,刘茜茜.MPV与PLT比值预测小肝癌患者并发微血管浸润的临床价值[J].实用癌症杂志,2024,39(1):145-148+153.
[17] GuY,ZhengF,ZhangY,etc.NovelNomogramBasedon Inflam matory Markers for the Preoperative Prediction of Microvas cular Invasion in Solitary Primary Hepatocellular Carcinoma [J].Cancer Management and Research,2022,14:895-907.
[18] Kaibori M, Ishizaki M, Matsui K, etc. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma[J].Journal of Surgical Oncology,2010,102(5):462-468.
[19] Zhou Q, Zhou C, Yin Y, etc. Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients[J]. Annals of Translational Medicine,2021,9(5):402.
[20] Liu W, Zhang L, Xin Z, etc. A Promising Preoperative Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Based on an Extreme Gradient Boosting Algorithm [J].Frontiers in Oncology,2022,12:852736.
[21] 郑华珍,雷秋成,陈展泽,等.异常凝血酶原联合甲胎蛋白预测肝细胞癌微血管侵犯的价值研究 [J].国际检验医学杂志,2023:1-8.
[22] ZhangC,ZhaoR,ChenF,etc.Preoperativepredictionofmicrovascularinvasioninnon-metastatichepatocellularcarcinoma based on nomogram analysis[J].Translational Oncology,2020,14(1):100875.
[23] 何羽童,黄晨军,王颖,等.基于临床实验室指标的HBV相关性原发性肝癌微血管侵犯预测模型的建立[J].临床检验杂志,2020,38(7):498–502.
[24] DreyfussG,KimVN,KataokaN.Messenger-RNA-binding proteins and the messages they carry[J].Nature Reviews Molec ular Cell Biology,2002,3(3):195-205.
[25] Mitchell S F, Parker R. Principles and properties of eukaryotic mRNPs[J].Molecular Cell,2014,54(4):547-558.
[26] Huang C, Wang Y, Liu S, etc. Quantitative Proteomic Analysis Identified Paraoxonase 1 as a Novel Serum Biomarker for Microvascular Invasion in Hepatocellular Carcinoma[J]. Journal of Proteome Research,American Chemical Society,2013,12(4):1838-1846.
[27] Poté N,Cros J,Laouirem S,etc.The histone acetyltrans ferase hMOF promotes vascular invasion in hepatocellular carc inoma[J].Liver International,2020,40(4):956-967.
[28] Qi L-N, Ma L, Wu F-X, etc. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma[J]. Hepatology International, 2021, 15(1):114-126.
[29] Huang F, Yang G, Jiang H, etc. Technology in Cancer Research & Treatment,2022,21:153303382211445.